Wandercraft's self-balancing rehabilitation exoskeleton Atalante X receives ARCSA approval in Ecuador, advancing Latin American expansion

Wandercraft's self-balancing rehabilitation exoskeleton Atalante X has received approval from Ecuador's health regulator ARCSA for rehabilitation of patients with spinal cord injury (C4 to L5), post-stroke hemiplegia, and multiple sclerosis. The device balances autonomously without crutches and is already in use at more than 150 clinical and research institutions worldwide; La Clínica de Lesiones Deportivas in Quito will be the first center in Ecuador to introduce the device, and the company is also evaluating markets such as Costa Rica and Chile.